About | Support Us | Contact
Research Portfolio

Funding Opportunities

Join our Mailing List
Join our mailing list to be notified of new funding opportunities.

Your Email

To receive information about funding opportunities, events, and program updates.
Home Page > Investigator Page

Michael Kelner, M.D., M.S.

University of California, San Diego # of Grants: 6

Grants
Cloning of a Lung Tumor Transport Gene for Drug Development 1995 (Cycle 4) $104,966
Cancer Inno Dev & Exp Awards (IDEAS)
SAR Studies of Novel antitumor Agents for Lung Carcinomas 1995 (Cycle 4) $403,338
Cancer Research Project Awards
Isolation of lung tumor proteins for a novel treatment 1998 (Cycle 7) $75,000
Cancer Inno Dev & Exp Awards (IDEAS)
Studies of novel antitumor agents for lung cancers 1998 (Cycle 7) $306,000
Cancer Research Project Awards
Preclinical Studies of Novel Agents for Lung Cancer 1992 (Cycle 1) $225,000
Cancer New Investigator Awards
Studies of novel antitumor agents for lung carcinoma 2000 (Cycle 9) $833,491
Cancer Research Project Awards
Publications
The design and total synthesis of antitumor Acylfulvenes
Periodical: Journal of Organics Chemistry Index Medicus:
Authors: McMorris TC, Yu J, Hi Y, et al ART
Yr: 1997 Vol: 62 Nbr: Abs: Pg: 3015-3018
The design and total synthesis of antitumor Acylfulvenes
Periodical: Journal of Organics Chemistry Index Medicus:
Authors: McMorris TC, Yu J, Hi Y, et al ART
Yr: 1997 Vol: 62 Nbr: Abs: Pg: 3015-3018
Characterization of illudin S sensitivity in DNA repair-deficient Chinese hamster cells: unusually high sensitivity of ERCC2 and ERCC3 DNA helicase deficient mutants in comparison to other chemotherapeutic agents
Periodical: Biochemical Pharmacology Index Medicus:
Authors: Kelner MJ, McMorris L, Estes M, et al ART
Yr: 1994 Vol: 48 Nbr: 2 Abs: Pg: 403-409
Nonresponsiveness of the metastatic human lung carcinoma MV522 xenograft to conventional anticancer agents
Periodical: Anticancer Research Index Medicus:
Authors: Kelner MJ, McMorris TC, Estes L, et al ART
Yr: 1995 Vol: 15 Nbr: 3 Abs: Pg: 867-872
In vitro and in vivo studies on the anticancer activity of dehydroilludin M
Periodical: Anticancer Research Index Medicus:
Authors: Kelner MJ, McMorris TC, Taetle R ART
Yr: 1995 Vol: 15 Nbr: 3 Abs: Pg: 873-878
Efficacy of Acylfulvene Illudin analogs against a metastatic lung carcinoma MV522 xenograft nonresponsive to traditional anticancer agents retention of activity against various phenotypes.
Periodical: Cancer Research Index Medicus:
Authors: Kelner MJ, McMorris TC, Estes L, et al ART
Yr: 1995 Vol: 55 Nbr: 21 Abs: Pg: 4936-4940
Acylfulvenes, a new class of potent antitumor agents
Periodical: Experientia Index Medicus:
Authors: McMorris TC, Kelner MJ, Wang W, Diaz MA, Estes LA, Taetle R ART
Yr: 1996 Vol: 52 Nbr: (1) Abs: Pg: 75-80
Efficacy of HMAF (MGI-114-02) in the MV522 metastatic lung carcinoma xenograft model nonresponsive to traditional anticancer agents
Periodical: Investigational New Drugs Index Medicus:
Authors: Kelner MJ, McMorris TC, Estes L, et al ART
Yr: 1996 Vol: 14 Nbr: Abs: Pg: 161-167
Hydroxymethylacylfulvene: an Illudin derivative with superior antitumor properties
Periodical: Journal of Natural Products Index Medicus:
Authors: McMorris TC, Kelner MJ, Wang W, et al ART
Yr: 1996 Vol: 59 Nbr: Abs: Pg: 896-899
Characterization of cellular accululation and toxicity of Illudin S in sensitive and non-sensitive tumor cells
Periodical: Cancer Chemotherapy and Pharmacology Index Medicus:
Authors: Kelner MJ, McMorris TC, Montoya MA, et al ART
Yr: 1997 Vol: 40 Nbr: Abs: Pg: 65-71
Characterization of Acylfulvene histiospecific toxicity in human tumor cell lines
Periodical: Cancer Chemotherapy and Pharmacology Index Medicus:
Authors: Kelner MJ, McMorris TC, Montoya MA, et al ART
Yr: 1998 Vol: 41 Nbr: Abs: Pg: 237-242
Reaction of antitumor hydroxymethylacylfulvene (HMAF) with thiols
Periodical: Tetrahedron Letters Index Medicus:
Authors: McMorris TC, Yu J, Estes LA, Kelner MJ ART
Yr: 1997 Vol: 53 Nbr: Abs: Pg: 14579-14590
Efficacy of MGI 114 (6-hydroxymethylfulvene, HMAF)against the mdrI/gp170 Metastatic MV522 lung carcinoma xenograft
Periodical: European Journal of Cancer Index Medicus:
Authors: Kelner MJ, McMorris TC, Estes L, et al ART
Yr: 1998 Vol: 34 Nbr: Abs: Pg: 908-913
Characterization of illudin S sensitivity in DNA repair-deficient Chinese hamster cells: unusually high sensitivity of ERCC2 and ERCC3 DNA helicase deficient mutants in comparison to other chemotherapeutic agents
Periodical: Biochemical Pharmacology Index Medicus:
Authors: Kelner MJ, McMorris L, Estes M, et al ART
Yr: 1994 Vol: 48 Nbr: 2 Abs: Pg: 403-409
Nonresponsiveness of the metastatic human lung carcinoma MV522 xenograft to conventional anticancer agents
Periodical: Anticancer Research Index Medicus:
Authors: Kelner MJ, McMorris TC, Estes L, et al ART
Yr: 1995 Vol: 15 Nbr: 3 Abs: Pg: 867-872
In vitro and in vivo studies on the anticancer activity of dehydroilludin M
Periodical: Anticancer Research Index Medicus:
Authors: Kelner MJ, McMorris TC, Taetle R ART
Yr: 1995 Vol: 15 Nbr: 3 Abs: Pg: 873-878
Efficacy of Acylfulvene Illudin analogs against a metastatic lung carcinoma MV522 xenograft nonresponsive to traditional anticancer agents retention of activity against various phenotypes.
Periodical: Cancer Research Index Medicus:
Authors: Kelner MJ, McMorris TC, Estes L, et al ART
Yr: 1995 Vol: 55 Nbr: 21 Abs: Pg: 4936-4940
Acylfulvenes, a new class of potent antitumor agents
Periodical: Experientia Index Medicus:
Authors: McMorris TC, Kelner MJ, Wang W, Diaz MA, Estes LA, Taetle R ART
Yr: 1996 Vol: 52 Nbr: (1) Abs: Pg: 75-80
Efficacy of HMAF (MGI-114-02) in the MV522 metastatic lung carcinoma xenograft model nonresponsive to traditional anticancer agents
Periodical: Investigational New Drugs Index Medicus:
Authors: Kelner MJ, McMorris TC, Estes L, et al ART
Yr: 1996 Vol: 14 Nbr: Abs: Pg: 161-167
Hydroxymethylacylfulvene: an Illudin derivative with superior antitumor properties
Periodical: Journal of Natural Products Index Medicus:
Authors: McMorris TC, Kelner MJ, Wang W, et al ART
Yr: 1996 Vol: 59 Nbr: Abs: Pg: 896-899
Characterization of cellular accululation and toxicity of Illudin S in sensitive and non-sensitive tumor cells
Periodical: Cancer Chemotherapy and Pharmacology Index Medicus:
Authors: Kelner MJ, McMorris TC, Montoya MA, et al ART
Yr: 1997 Vol: 40 Nbr: Abs: Pg: 65-71
Characterization of Acylfulvene histiospecific toxicity in human tumor cell lines
Periodical: Cancer Chemotherapy and Pharmacology Index Medicus:
Authors: Kelner MJ, McMorris TC, Montoya MA, et al ART
Yr: 1998 Vol: 41 Nbr: Abs: Pg: 237-242
Reaction of antitumor hydroxymethylacylfulvene (HMAF) with thiols
Periodical: Tetrahedron Letters Index Medicus:
Authors: McMorris TC, Yu J, Estes LA, Kelner MJ ART
Yr: 1997 Vol: 53 Nbr: Abs: Pg: 14579-14590
Efficacy of MGI 114 (6-hydroxymethylfulvene, HMAF)against the mdrI/gp170 Metastatic MV522 lung carcinoma xenograft
Periodical: European Journal of Cancer Index Medicus:
Authors: Kelner MJ, McMorris TC, Estes L, et al ART
Yr: 1998 Vol: 34 Nbr: Abs: Pg: 908-913
Metabolism of antitumor Acylfulvene by rat liver cytosol
Periodical: Biochemical Pharmacology Index Medicus:
Authors: McMorris TC, Elayadi AN, Yu J, Kelner MJ ART
Yr: 1999 Vol: 57 Nbr: Abs: Pg: 83-88
Characterization of MGI 114 (HMAF): Histiospecific toxicity in human tumor cell lines
Periodical: Cancer Chemotherapy and Pharmacology Index Medicus:
Authors: Kelner MJ, McMorris TC, Montoya MA, et al ART
Yr: 1999 Vol: Nbr: Abs: Pg:
Metabolism of antitumor MGI 114 (HMAF) rat liver cytosol
Periodical: Drug Metabolism and Disposition Index Medicus:
Authors: McMorris TC, Elayadi AN, Yu J, Hu Y, Kelner MJ ART
Yr: 1999 Vol: Nbr: Abs: Pg:
Efficacy of MGIII 114 against the MRP-positive metastatic MV522 lung carcinoma xenograft
Periodical: Anti-cancer Drugs Index Medicus:
Authors: Kelner, MJ, McMorris TC, Estes MY, et al ART
Yr: 2000 Vol: 11 Nbr: Abs: Pg: 217-224
Anti-leukemic action of the novel agent MGI 114 HMAF and synergistic action with Topotecan
Periodical: Leukemia Index Medicus:
Authors: Kelner MJ, McMorris TC, Estes KM, et al ART
Yr: 2000 Vol: 14 Nbr: Abs: Pg: 136-141
Metabolism of antitumor Acylfulvene by rat liver cytosol
Periodical: Biochemical Pharmacology Index Medicus:
Authors: McMorris TC, Elayadi AN, Yu J, Kelner MJ ART
Yr: 1999 Vol: 57 Nbr: Abs: Pg: 83-88
Characterization of MGI 114 (HMAF): Histiospecific toxicity in human tumor cell lines
Periodical: Cancer Chemotherapy and Pharmacology Index Medicus:
Authors: Kelner MJ, McMorris TC, Montoya MA, et al ART
Yr: 1999 Vol: Nbr: Abs: Pg:
Metabolism of antitumor MGI 114 (HMAF) rat liver cytosol
Periodical: Drug Metabolism and Disposition Index Medicus:
Authors: McMorris TC, Elayadi AN, Yu J, Hu Y, Kelner MJ ART
Yr: 1999 Vol: Nbr: Abs: Pg:
Efficacy of MGIII 114 against the MRP-positive metastatic MV522 lung carcinoma xenograft
Periodical: Anti-cancer Drugs Index Medicus:
Authors: Kelner, MJ, McMorris TC, Estes MY, et al ART
Yr: 2000 Vol: 11 Nbr: Abs: Pg: 217-224
Anti-leukemic action of the novel agent MGI 114 HMAF and synergistic action with Topotecan
Periodical: Leukemia Index Medicus:
Authors: Kelner MJ, McMorris TC, Estes KM, et al ART
Yr: 2000 Vol: 14 Nbr: Abs: Pg: 136-141
Preclinical evaluation of illudins as anti-cancer agents: Basis for selective cytotoxicity
Periodical: Journal of the National Cancer Institute Index Medicus:
Authors: Kelner MJ, McMorris TC, Taetle R ART
Yr: 1990 Vol: 82 Nbr: Abs: Pg: 1562-1565
HPLC determination of a new anticancer agent (acylfulvene) in serum
Periodical: Neoplasma Index Medicus:
Authors: Brandsteterova E, Kelner MJ, McMorris TC, Estes L, Bagnell R, Montoya M ART
Yr: 1992 Vol: 39 Nbr: 6 Abs: Pg: 369-373
Structure activity-relationships of illudins: analogs with improved therapeutic index
Periodical: Index Medicus:
Authors: McMorris TC, Kelner MJ, Wang W, Estes LA, Montoya MM, Taetle R ART
Yr: 1992 Vol: 57 Nbr: 25 Abs: Pg: 6876-6883
HPLC analysis of novel anticancer agents - illudins and their analogs
Periodical: Journal of Liquid Chromatography Index Medicus:
Authors: Brandsteterova E, Kelner MJ, McMorris TC, Wang W, Bagnell R ART
Yr: 1993 Vol: 16 Nbr: 1 Abs: Pg: 115-125
On the mechanism of toxicity of illudins
Periodical: Index Medicus:
Authors: McMorris TC, Kelner MJ, Wang W, Moon S, Taetle R ART
Yr: 1990 Vol: 3 Nbr: Abs: Pg: 574-579
Preclinical evaluation of illudins as anti-cancer agents: Basis for selective cytotoxicity
Periodical: Journal of the National Cancer Institute Index Medicus:
Authors: Kelner MJ, McMorris TC, Taetle R ART
Yr: 1990 Vol: 82 Nbr: Abs: Pg: 1562-1565
HPLC determination of a new anticancer agent (acylfulvene) in serum
Periodical: Neoplasma Index Medicus:
Authors: Brandsteterova E, Kelner MJ, McMorris TC, Estes L, Bagnell R, Montoya M ART
Yr: 1992 Vol: 39 Nbr: 6 Abs: Pg: 369-373
Structure activity-relationships of illudins: analogs with improved therapeutic index
Periodical: Index Medicus:
Authors: McMorris TC, Kelner MJ, Wang W, Estes LA, Montoya MM, Taetle R ART
Yr: 1992 Vol: 57 Nbr: 25 Abs: Pg: 6876-6883
HPLC analysis of novel anticancer agents - illudins and their analogs
Periodical: Journal of Liquid Chromatography Index Medicus:
Authors: Brandsteterova E, Kelner MJ, McMorris TC, Wang W, Bagnell R ART
Yr: 1993 Vol: 16 Nbr: 1 Abs: Pg: 115-125
On the mechanism of toxicity of illudins
Periodical: Index Medicus:
Authors: McMorris TC, Kelner MJ, Wang W, Moon S, Taetle R ART
Yr: 1990 Vol: 3 Nbr: Abs: Pg: 574-579
Structure-activity studies of antitumor agent irofulven (hydroxymethylacylfulvene) and related analogues.
Periodical: Journal of Organics Chemistry Index Medicus:
Authors: McMorris TC, Yu J, Lira R, Dawe R, MacDonald JR, and Kelner MJ ART
Yr: 2001 Vol: 6 Nbr: Abs: Pg: 6158 - 6163
Enhanced antitumor activity of irofulven in combination with thiotepa or mitomycin C.
Periodical: Cancer Chemotherapy and Pharmacology Index Medicus:
Authors: Kelner MJ, McMorris TC, Rojas RJ, Trani NA and Estes I ART
Yr: 2002 Vol: 49 Nbr: Abs: Pg: 412-418
Anti-leukemic action of the novel agent MGI 114 (HMAF) and synergistic action with Topotecan.
Periodical: Leukemia Index Medicus:
Authors: Kelner M, McMorris TC, Estes L, Samson KM, Trani NA, MacDonald JR ART
Yr: 2000 Vol: 14 Nbr: Abs: Pg: 136-141
Efficacy of MGI 114 against the MRP-positive metastatic MV522 lung carcinoma xenograft.
Periodical: Anti-cancer Drugs Index Medicus:
Authors: Kelner MJ, McMorris TC, Estes LA, Oval MY, Rojas RJ, Lynn JR, Lanham KA, Samson KM. ART
Yr: 2000 Vol: 11 Nbr: Abs: Pg: 217-224
Preparation and biological activity of amino acid and peptide conjugates of antitumor hyroxylmethylacylfulvene.
Periodical: Journal of Medicinal Chemistry Index Medicus:
Authors: McMorris TC, Yu J, Ngo HT, Wang H, Kelner MJ ART
Yr: 2000 Vol: 43 Nbr: Abs: Pg: 3577-3580
Sequiterpenes from the basidiomycete omphalotus illudens.
Periodical: Journal of Natural Products Index Medicus:
Authors: McMorris TC, Lira R, Gantzel PK, Kelner MJ, Dawe R ART
Yr: 2000 Vol: 63 Nbr: Abs: Pg: 1557-1559
Structure-activity studies of antitumor agent irofulven (HMAF) and related analogues.
Periodical: Journal of Organics Chemistry Index Medicus:
Authors: McMorris TC, Yu J, Lira R, Dawe R, MacDonald JR, Kelner MJ ART
Yr: 2001 Vol: 6 Nbr: Abs: Pg: 6158-6163
Enhanced antitumor activity of irofulven in combination with antimitotics.
Periodical: Investigational New Drugs Index Medicus:
Authors: Kelner MJ, McMorris TC, Rojas RJ, Trani NA, Estes L ART
Yr: 2002 Vol: 20 Nbr: Abs: Pg: 267-279
Sesquiterpenes from omphalotus illudens
Periodical: Phytochemistry Index Medicus:
Authors: McMorris, Kashinatham A, Lira R, Rundgren H, Gantzel PK, Kelner MJ, Dawes R ART
Yr: 2002 Vol: 61 Nbr: Abs: Pg: 395-398
Genotoxic action of anti-tumor illudin compounds including irufulven.
Periodical: DNA Repair Index Medicus:
Authors: Jaspers NGJ, Raams A, Kelner MJ, Ng J, Takeda S, McMorris, Hoeijmakers JHJ ART
Yr: 2002 Vol: 11 Nbr: Abs: Pg: 1027-1038
Reaction of irofulven with zinc and acid
Periodical: Journal of Natural Products Index Medicus:
Authors: McMorris TC, Moon S, Kelner MJ ART
Yr: 2003 Vol: 66 Nbr: Abs: Pg: 310-312
Structure-activity studies of antitumor agent irofulven (hydroxymethylacylfulvene) and related analogues.
Periodical: Journal of Organics Chemistry Index Medicus:
Authors: McMorris TC, Yu J, Lira R, Dawe R, MacDonald JR, and Kelner MJ ART
Yr: 2001 Vol: 6 Nbr: Abs: Pg: 6158 - 6163
Enhanced antitumor activity of irofulven in combination with thiotepa or mitomycin C.
Periodical: Cancer Chemotherapy and Pharmacology Index Medicus:
Authors: Kelner MJ, McMorris TC, Rojas RJ, Trani NA and Estes I ART
Yr: 2002 Vol: 49 Nbr: Abs: Pg: 412-418
Anti-leukemic action of the novel agent MGI 114 (HMAF) and synergistic action with Topotecan.
Periodical: Leukemia Index Medicus:
Authors: Kelner M, McMorris TC, Estes L, Samson KM, Trani NA, MacDonald JR ART
Yr: 2000 Vol: 14 Nbr: Abs: Pg: 136-141
Efficacy of MGI 114 against the MRP-positive metastatic MV522 lung carcinoma xenograft.
Periodical: Anti-cancer Drugs Index Medicus:
Authors: Kelner MJ, McMorris TC, Estes LA, Oval MY, Rojas RJ, Lynn JR, Lanham KA, Samson KM. ART
Yr: 2000 Vol: 11 Nbr: Abs: Pg: 217-224
Preparation and biological activity of amino acid and peptide conjugates of antitumor hyroxylmethylacylfulvene.
Periodical: Journal of Medicinal Chemistry Index Medicus:
Authors: McMorris TC, Yu J, Ngo HT, Wang H, Kelner MJ ART
Yr: 2000 Vol: 43 Nbr: Abs: Pg: 3577-3580
Sequiterpenes from the basidiomycete omphalotus illudens.
Periodical: Journal of Natural Products Index Medicus:
Authors: McMorris TC, Lira R, Gantzel PK, Kelner MJ, Dawe R ART
Yr: 2000 Vol: 63 Nbr: Abs: Pg: 1557-1559
Structure-activity studies of antitumor agent irofulven (HMAF) and related analogues.
Periodical: Journal of Organics Chemistry Index Medicus:
Authors: McMorris TC, Yu J, Lira R, Dawe R, MacDonald JR, Kelner MJ ART
Yr: 2001 Vol: 6 Nbr: Abs: Pg: 6158-6163
Enhanced antitumor activity of irofulven in combination with antimitotics.
Periodical: Investigational New Drugs Index Medicus:
Authors: Kelner MJ, McMorris TC, Rojas RJ, Trani NA, Estes L ART
Yr: 2002 Vol: 20 Nbr: Abs: Pg: 267-279
Sesquiterpenes from omphalotus illudens
Periodical: Phytochemistry Index Medicus:
Authors: McMorris, Kashinatham A, Lira R, Rundgren H, Gantzel PK, Kelner MJ, Dawes R ART
Yr: 2002 Vol: 61 Nbr: Abs: Pg: 395-398
Genotoxic action of anti-tumor illudin compounds including irufulven.
Periodical: DNA Repair Index Medicus:
Authors: Jaspers NGJ, Raams A, Kelner MJ, Ng J, Takeda S, McMorris, Hoeijmakers JHJ ART
Yr: 2002 Vol: 11 Nbr: Abs: Pg: 1027-1038
Reaction of irofulven with zinc and acid
Periodical: Journal of Natural Products Index Medicus:
Authors: McMorris TC, Moon S, Kelner MJ ART
Yr: 2003 Vol: 66 Nbr: Abs: Pg: 310-312